Pocket Psychiatry A Carlat Podcast public
[search 0]
More

Download the App!

show episodes
 
Loading …
show series
 
Psychotic depression. Conrad Swartz shows us how to recognize this underdiagnosed illness, and why antipsychotics and antidepressants may not be the optimal treatment. CME: Podcast CME Post-Tests are available using this subscription. If you have already enrolled in that program, please log in. Published On: 06/20/2022 Duration: 18 minutes, 27 seco…
 
Why is it important for providers to understand how vaping devices work and what type of information should we be providing our patients with? CME: Take the Podcast CME Post-Test here. Not subscribed to earn CME credit for listening? Click here to start earning CME credit for podcast episodes! Published On: 06/13/2022 Duration: 30 minutes, 25 secon…
 
12 clinically relevant findings from the past 3 years on quetiapine (Seroquel), including new side effects, dosing strategies, withdrawal phenomena, and new uses in bipolar with OCD. CME: Podcast CME Post-Tests are available using this subscription. If you have already enrolled in that program, please log in. Published On: 06/6/2022 Duration: 20 mi…
 
The validity of bipolar disorder in children and adolescents has long been debated, and the history surrounding this diagnosis is controversial to say the least. In this podcast, we will discuss the evidence supporting whether bipolar disorder presents in youth, and how clinicians can best assess this disorder. CME: Take the CME Post-Test for this …
 
Tricyclics are much better tolerated than their reputation suggests, and countdown 6 reasons to use them, from melancholic depression to irritable bowel syndrome. CME: Podcast CME Post-Tests are available using this subscription. If you have already enrolled in that program, please log in. Published On: 05/23/2022 Duration: 14 minutes, 16 seconds C…
 
When patients are not amenable to usual therapy, equine-assisted psychotherapy (EAP) might be a good option. In this podcast we’ll talk about working with horses as an alternative to, or in conjunction with, traditional therapy. CME: Take the Podcast CME Post-Test here. Not subscribed to earn CME credit for listening? Click here to start earning CM…
 
To start a conversation about race, you need to know the lingo. We interview psychiatrist Kali Cyrus on internalized racism, microaggressions, implicit bias, and more. CME: Take the Podcast CME Post-Test here. Not subscribed to earn CME credit for listening? Click here to start earning CME credit for podcast episodes! Published On: 05/09/2022 Durat…
 
Do anticholinergic medications increase the risk of long-term cognitive decline and dementia? In this podcast, we will review the latest research examining the relationship between anticholinergic medication use and cognitive decline. CME: Take the Podcast CME Post-Test here. Not subscribed to earn CME credit for listening? Click here to start earn…
 
Dr. Tammas Kelly shares tips on high dose thyroid in treatment-resistant bipolar depression. CME: Take the Podcast CME Post-Test here. Not subscribed to earn CME credit for listening? Click here to start earning CME credit for podcast episodes! Published On: 04/25/2022 Duration: 14 minutes, 00 seconds Related Article: “Thyroid Augmentation in Bipol…
 
ADHD is one of the most treatable conditions in psychiatry if patients adhere to medication regimens. So, why are parents so resistant to stimulant medications and how can we approach these misconceptions? CME: Take the Podcast CME Post-Test here. Not subscribed to earn CME credit for listening? Click here to start earning CME credit for podcast ep…
 
A recent paper lists 5 therapies for treatment-resistant depression, but the research keeps rolling in, and we bring you 2 more to add to the list. CME: Take the Podcast CME Post-Test here. Not subscribed to earn CME credit for listening? Click here to start earning CME credit for podcast episodes! Published On: 04/18/2022 Duration: 20 minutes, 15 …
 
We often hear about the “Tarasoff warning” and the “duty to protect,” but what do these mean, and who was Tarasoff? In today’s episode, we’ll break down the Tarasoff rulings and how you can navigate the legal ambiguities surrounding our duty to protect. CME: Take the Podcast CME Post-Test here. Not subscribed to earn CME credit for listening? Click…
 
From psychotherapy to ECT, pramipexole to lamotrigine, a walk through 20 therapies for bipolar depression. CME: Take the Podcast CME Post-Test here. Not subscribed to earn CME credit for listening? Click here to start earning CME credit for podcast episodes! Published On: 04/11/2022 Duration: 25 minutes, 18 seconds Related Article: “A Practical Gui…
 
Zuranolone is a neurosteroid that is inching its way toward FDA approval in depression. In some ways it’s similar to brexanolone (Zulresso) – the IV therapy approved in 2019 for postpartum depression – and in other ways it’s different. CME: Take the CME Post-Test for this episode Published On: 04/04/2022 Duration: 12 minutes, 20 seconds Related Art…
 
Borderline personality disorder can be complicated to treat, especially in frantic and high stress settings like the emergency department or inpatient psychiatric unit. In today’s episode, we’ll address the best practices for managing patients with borderline personality disorder in emergency settings. CME: Take the CME Post-Test for this episode P…
 
Naloxone saves lives, and it’s critical that we get naloxone into the hands of as many people as we can. In this podcast, Dr. Phillip Coffin and I will discuss the risk factors associated with opioid overdose, the different naloxone formulations, who should be prescribed naloxone, and how we as clinicians can promote the availability of naloxone in…
 
Margaret Chisolm, MD, shares a model of flourishing that moves beyond symptomatic treatment and helps patients find meaningful lives even when their medications do not work. CME: Take the CME Post-Test for this episode Published On: 03/21/2022 Duration: 15 minutes, 24 seconds Related Articles: “Mental Illness and Flourishing,” The Carlat Psychiatry…
 
Each year in the US, there are about 1.04 million divorces, affecting about 800,000 children, and it may not be the divorce itself that is hard on children, but how the divorce is handled. How can we navigate the complexities of treating a child with divorced or separated parents? CME: Take the CME Post-Test here. Published On: 03/17/2022 Duration:…
 
A new app for insomnia might also lift depression. We show you how it works and end with 7 practical tips to share with your patients who have insomnia. CME: Take the CME Post-Test for this episode Published On: 03/14/2022 Duration: 30 minutes, 24 seconds Related Article: “A Prescription App for Insomnia,” The Carlat Psychiatry Report, March 2022 C…
 
Can we treat depression by targeting inflammation? Do SSRIs for post-stroke depression increase the risk of second intracranial hemorrhage? And how effective is the new combination treatment, olanzapine/samidorphan, for mitigating antipsychotic-induced weight gain? We will answer these questions in this Hospital Psychiatry Research Update Extravaga…
 
Omega-3 fatty acids do treat depression, but not with the formulations that are commonly found on the shelves. Here we point you in the right direction, and give a winding origin story of these essential fatty acids. CME: Take the CME Post-Test for this episode Published On: 03/07/2022 Duration: 22 minutes, 21 seconds Chris Aiken, MD, and Kellie Ne…
 
Do Antipsychotics Have Neurotoxic Effects in Youth? In this episode, we’ll be banging the drum of caution about antipsychotic use in children and adolescents. CME: Take the CME Post-Test for this episode Published On: 03/03/2022 Duration: 11 minutes, 21 seconds Related Article: “Exploring the Potential Neurotoxicity of Antipsychotics in Younger Pop…
 
Lybalvi combines olanzapine with the opioid blocker samidorphan in hopes of curbing the weight gain on that antipsychotic. Here, we look at how well it works. CME: Take the CME Post-Test for this episode Published On: 02/28/2022 Duration: 25 minutes, 03 seconds Earn CME credits for this episode through the link in the podcast notes, and if you have…
 
Methamphetamine is the second most abused drug in the U.S. We bring you up to speed on the basics in this episode. CME: Take the CME Post-Test for this episode Published On: 02/21/2022 Duration: 20 minutes, 52 seconds Related Article: “A Novel Treatment for Methamphetamine Use Disorder,” The Carlat Psychiatry Report, February 2022. Chris Aiken, MD,…
 
The new APA guidelines on schizophrenia go above and beyond the usual standards. Brian Miller shows us how to catch up. CME: Take the CME Post-Test for this episode Published On: 02/14/2022 Duration: 25 minutes, 58 seconds Related Article: “Raising the Bar in Schizophrenia Treatment,” The Carlat Psychiatry Report, February 2022 Earn CME credits for…
 
The pharmaceutical industry created 3 myths around opioids: “Pain as the fifth vital sign,” the less-than-1% rate of addiction, and the diagnosis of pseudoaddiction. Inside, we look at what is true and what is exaggeration in these claims. CME: Take the CME Post-Test for this episode Published On: 02/07/2022 Duration: 17 minutes, 07 seconds Related…
 
A new Hulu series portrays the pharmaceutical industry’s role in the opioid crisis, but how much of it is real and how much is entertainment? CME: Take the CME Post-Test for this episode Published On: 01/31/2022 Duration: 22 minutes, 24 seconds Chris Aiken, MD, and Kellie Newsome, PMHNP, have disclosed no relevant financial or other interests in an…
 
Lumateperone (Caplyta) just got FDA approved for bipolar depression. Find out how it compares to other atypical antipsychotics. CME: Take the CME Post-Test For This Episode Published On: 01/24/2022 Duration: 24 minutes, 09 seconds Chris Aiken, MD, and Kellie Newsome, PMHNP, have disclosed no relevant financial or other interests in any commercial c…
 
Psychoanalyst Dan Buie describes 5 deficits that cause great suffering for people with personality disorders and how to work with them in therapy. CME: Take the CME Post-Test Published On: 01/17/2022 Duration: 18 minutes, 39 seconds Related Article: “Working With Severe Personality Disorders,” The Carlat Psychiatry Report, January 2022 Chris Aiken,…
 
Psychoanalyst Dan Buie describes hateful reactions that are common when working with suicidal patients and how to manage these intense emotions CME: Take the CME Post-Test for this episode Published On: 01/10/2022 Duration: 9 minutes, 16 seconds Chris Aiken, MD, has disclosed no relevant financial or other interests in any commercial companies pert…
 
In 2021 we uncovered some paradoxical effects of medications, including meds that can both cause and treat OCD (antipsychotics), depression (benzodiazepines and antidepressants), and cognitive problems (stimulants and anti-dementia medications). CME: Take the CME Post-Test for this episode Published On: 01/03/2022 Duration: 16 minutes, 0 seconds Re…
 
DHHS recently unveiled the first major overhaul of its documentation guidelines for the E&M codes often used in outpatient psychiatry. We show you how to make those rules work for your patients. CME: Take the CME Post-Test for this episode Published On: 12/27/2021 Duration: 24 minutes, 16 seconds Chris Aiken, MD, and Kellie Newsome, PMHNP, have dis…
 
Gordon Parker suggests changes to the DSM-5 criteria for bipolar disorder, and unveils a new screening instrument that aims to separate hypomania from normal happiness. CME: Clinicians enrolled in our Podcast CME Subscription can access the post-test here. Published On: 12/20/2021 Duration: 16 minutes, 07 seconds Referenced Article: “How to Diagnos…
 
You will hear about and read research your entire career. Headlines report on positive treatment results, and families come in asking about them. So how should we evaluate research, and what makes a study good or flawed? CME: Clinicians enrolled in our Podcast CME Subscription can access the post-test here. Published On: 12/17/2021 Duration: 17 min…
 
For years, we have dreaded seeing our patients develop antipsychotic-induced tardive dyskinesia because there was little we could do about these symptoms. Thankfully, we now have new treatments that produce noticeable improvements in tardive dyskinesia. CME: Clinicians enrolled in our Podcast CME Subscription can access the post-test here. Publishe…
 
Peter Whitehouse on how to prevent dementia and the limits of pharmacotherapy for cognitive decline. And the word of the day: Ultradian cycling. CME: Clinicians enrolled in our Podcast CME Subscription can access the post-test here. Published On: 12/13/2021 Duration: 21 minutes, 12 seconds Referenced Article: “In the News: Aducanumab (Aduhelm),” Th…
 
Pregnant patients with substance use disorder want to do what’s right for their pregnancy, and as clinicians, we need to be supportive and acknowledge our patients courage and vulnerability to seek help. But, what are the best treatments for the various substance use disorders in pregnant women, and which substances have the highest potential for p…
 
From melatonin for sleep-onset insomnia to electroconvulsive therapy for severe adolescent mood disorder to steroid-induced psychosis to the risk of stimulant-induced psychosis in youth with ADHD, and MORE! In this two-part series, Mara and Dr. Feder will tackle various research topics in the field of child psychiatry. CME: Clinicians enrolled in o…
 
Individuals with schizophrenia are at high risk of obesity, elevated lipids, increased insulin resistance, diabetes, and cardiovascular disease. On average, people with schizophrenia die 20–25 years sooner than those without schizophrenia. How can we spot metabolic side effects early in our patients, and what should we be looking for exactly? CME: …
 
From melatonin for sleep-onset insomnia to electroconvulsive therapy for severe adolescent mood disorder to steroid-induced psychosis to the risk of stimulant-induced psychosis in youth with ADHD, and MORE! In this episode, Mara and Dr. Feder will tackle various research topics in the field of child psychiatry. CME: Clinicians enrolled in our Podca…
 
In 2004, the well-known pediatric OCD treatment study also known as POTS study revealed that CBT and sertraline had comparable benefits over 12 weeks of treatment for children with OCD. Yet this study left us with a few unanswered questions. For instance, for those who don't respond to initial CBT therapy, should we continue CBT or switch to an SSR…
 
An interview with Drew Ramsey on nutritional psychiatry. Chris Aiken, MD, Kellie Newsome, PMHNP, and Drew Ramsey, MD, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity. CME: Clinicians enrolled in our Podcast CME Subscription can access the post-test here. Published On: 11/29…
 
How does schizophrenia differ between men and women? And are there adjunctive treatments that can improve outcomes for female patients with schizophrenia? In this podcast, Dr. Kulkarni and I will tackle these questions. CME: Clinicians enrolled in our Podcast CME Subscription can access the post-test here. Published On: 11/22/2021 Duration: 23 minu…
 
We break down the three main autism intervention approaches, and provide you with information that will help you improve on your abilities to recognize which particular autism intervention might be best for a specific patient. CME: Clinicians enrolled in our Podcast CME Subscription can access the post-test here. Published On: 11/17/2021 Duration: …
 
Aducanumab (Aduhelm) just got FDA approval in dementia, but many experts think it should not have passed the finish line. We interviewed Peter Whitehouse, professor of neurology at Case Western Reserve University and author of American Dementia, on what went wrong. CME: Clinicians enrolled in our Podcast CME Subscription can access the post-test he…
 
Patients with repeated deliberate foreign body ingestion (DFBI) are among the most challenging we see. In any given room, there’s bound to be some small object that can be swallowed. So how can we reduce the likelihood of foreign body ingestion in these patients? CME Credit: Clinicians enrolled in our Podcast CME Subscription can access the post-te…
 
In this 3-part series, we look at the rise and fall, and rise again of antipsychotics in mania, and sort through which ones work, which we should avoid, and whether their use in mania has gone overboard. Today, we lay out the top 3 antipsychotics for mania, and then throw out the whole idea of a rating system. Published On: 11/01/2021 Duration: 23 …
 
On April 30th of this year, the FDA approved Kloxxado, a naloxone nasal spray that contains 8mg of naloxone per dose, which is twice as much as the most common formulation: Narcan. But what distinguishes Kloxxado distinguishes from the many other ways that naloxone is delivered and why was it developed in the first place? Published On: 8/16/2021 Du…
 
In this 3-part series, we look at the rise and fall, and rise again of antipsychotics in mania, and sort through which ones work, which we should avoid, and whether their use in mania has gone overboard. Today, we lay out the top 3 antipsychotics for mania, and then throw out the whole idea of a rating system. Published On: 10/25/2021 Duration: 15 …
 
In this 3-part series, we look at the rise and fall, and rise again of antipsychotics in mania, and sort through which ones work, which we should avoid, and whether their use in mania has gone overboard. Today, how an anesthetic agent turned into an antipsychotic, and how Bing Crosby lit a spark that would eventually lead psychiatrists to revise th…
 
Loading …

Quick Reference Guide

Copyright 2022 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login